W.R. Berkley Corp’s Amgen AMGN Stock Holding History

W.R. Berkley Corp’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-39,700	Closed	-$11.4M	–	158
2023 Q4	$11.4M	Buy	+39,700	New	+$10.8M	0.83%	17

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

W.R. Berkley Corp's AMGN Position: Q1 2024 in Review

W.R. Berkley Corp sold out of Amgen (AMGN) in Q1 2024, closing a stake of 39,700 shares — an estimated $11.4M sold.

W.R. Berkley Corp first reported a position in AMGN in Q4 2023 and held it in 1 quarter. The position peaked at $11.4M in Q4 2023. 2,716 funds tracked by Wall St. Rank hold AMGN as of Q1 2024.

W.R. Berkley Corp reported no remaining Amgen position as of Q1 2024 after selling out during the quarter.
W.R. Berkley Corp sold 39,700 Amgen shares in Q1 2024, an estimated $11.4M.
W.R. Berkley Corp first reported a position in Amgen in Q4 2023 and held it in 1 quarter.
W.R. Berkley Corp's Amgen position peaked at $11.4M in Q4 2023.
2,716 funds tracked by Wall St. Rank held Amgen as of Q1 2024.

Based on W.R. Berkley Corp's 13F filing for Q1 2024, filed 15 May 2024.